Xuanzhu Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Jul '26 Jul 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,671	36,515	-	-	-	-
Enterprise Value	5,946	36,396	-	-	-	-
Last Close Price	12.88	70.50	-	-	-	-
PS Ratio	115.79	633.81	-	-	-	-
PB Ratio	4.38	23.95	-	-	-	-
P/TBV Ratio	5.80	31.77	-	-	-	-
EV/Sales Ratio	103.21	631.74	-	-	-	-
Debt / Equity Ratio	0	0	0.00	0.02	0.02	0
Net Debt / Equity Ratio	-0.48	-0.48	-0.26	-0.39	-0.68	-0.71
Net Debt / EBITDA Ratio	3.17	3.17	0.46	1.37	3.02	4.29
Net Debt / FCF Ratio	3.10	3.10	1.92	3.68	2.47	3.62
Asset Turnover	0.04	0.04	0.02	-	-	-
Inventory Turnover	0.36	0.36	0.26	-	-	-
Quick Ratio	3.04	3.04	1.45	3.24	19.95	14.26
Current Ratio	3.75	3.75	2.06	3.79	21.28	14.95
Return on Equity (ROE)	-21.10%	-21.10%	-53.84%	-	-29.47%	-16.87%
Return on Assets (ROA)	-10.28%	-10.28%	-27.99%	-	-15.83%	-14.54%
Return on Capital Employed (ROCE)	-16.50%	-16.50%	-55.40%	-28.80%	-23.00%	-17.70%
Earnings Yield	-4.10%	-0.75%	-	-	-	-
FCF Yield	-3.51%	-0.64%	-	-	-	-
Buyback Yield / Dilution	-3.15%	-3.15%	-	-14.22%	-	-